Non-Hodgkin Lymphoma

Conference Coverage

Regimen shows promise for ENKTL

The combination of pegaspargase, gemcitabine, and oxaliplatin (P-Gemox) elicited a high rate of response in this cohort of 60 Chinese patients. P...

Conference Coverage

A new prognostic model for PTCL?

Researchers analyzed nearly 9000 patients diagnosed with PTCL in the US and found evidence to suggest that patient age and race, as well as...

Pages